|
|
amine metabolic process
|
GO:0009308 |
45 |
0.595
|
|
|
|
positive regulation of exit from mitosis
|
GO:0031536 |
1 |
0.277
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.253
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.231
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.191
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.184
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.172
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.171
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.163
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.156
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.154
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.144
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.141
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.127
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.120
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.118
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.117
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.115
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.113
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.113
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.108
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.106
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.103
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.103
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.100
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.100
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.100
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.095
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.095
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.093
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.092
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.092
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.092
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.091
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.091
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.086
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.085
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.080
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.078
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.077
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.075
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.075
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.072
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.072
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.071
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.070
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.069
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.068
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.068
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.068
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.068
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.067
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.067
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.066
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.065
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.065
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.063
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.063
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.063
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.063
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.063
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.063
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.062
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.062
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.061
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.061
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.061
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.060
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.060
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.059
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.059
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.059
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.059
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.059
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.059
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.058
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.058
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.057
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.057
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.057
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.057
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.055
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.055
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.055
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.055
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.054
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.054
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.054
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.054
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.053
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.053
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.053
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.053
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.053
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.052
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.052
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.052
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.051
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.051
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.051
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.050
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.050
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.050
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.049
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.049
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.049
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.049
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.048
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.048
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.048
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.048
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.047
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.047
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.046
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.046
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.046
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.046
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.046
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.045
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.045
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.044
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.044
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.044
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.043
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.042
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.042
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.042
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.041
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.041
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.041
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.041
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.040
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.040
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.040
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
8 |
0.040
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.040
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.040
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.040
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.040
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.040
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.039
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.039
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.038
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.038
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.038
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.038
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.038
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.038
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.038
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.038
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.038
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.038
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.037
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.037
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.037
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.037
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.037
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.036
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.036
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.036
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.036
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.036
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.036
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.035
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.035
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.035
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.035
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.035
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.035
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.034
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.034
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.034
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.034
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.034
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.034
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.033
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.033
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.033
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.033
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.033
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.033
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.033
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.033
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.033
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.033
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.033
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.032
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.032
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.032
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.032
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.032
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.032
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.032
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.032
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.032
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.031
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.031
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.031
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.030
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.030
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.030
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.030
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.030
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.030
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.030
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.030
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.029
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.029
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.029
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.029
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.029
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.029
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.028
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.028
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.028
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.028
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.028
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.028
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.028
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.028
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.028
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.028
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.028
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.028
|
|
|
|
behavioral fear response
|
GO:0001662 |
28 |
0.028
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.028
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.028
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.027
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.027
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.027
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.027
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.027
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.027
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.027
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.027
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.027
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.026
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.026
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.026
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.026
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.026
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.026
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.026
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.026
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.026
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.026
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.026
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.026
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.026
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.026
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.026
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.026
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.025
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.025
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.025
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.025
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.025
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.025
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.025
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.025
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.025
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.025
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.025
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.025
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.025
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.025
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.024
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.024
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.024
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.024
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.024
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.024
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.024
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.024
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.024
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.024
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.024
|
|
|
|
deltoid tuberosity development
|
GO:0035993 |
3 |
0.024
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.024
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.024
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.023
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.023
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.023
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.023
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.023
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.023
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.023
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.023
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.023
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.023
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.023
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.023
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.023
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.023
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.023
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.023
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.023
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.023
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.023
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.023
|
|
|
|
regulation of multicellular organismal metabolic process
|
GO:0044246 |
14 |
0.023
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.023
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.023
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.023
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.022
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.022
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.022
|
|
|
|
platelet morphogenesis
|
GO:0036344 |
13 |
0.022
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.022
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.022
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.022
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.022
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.022
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.022
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.022
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.022
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.022
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.022
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.022
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.021
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.021
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.021
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.021
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.021
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.021
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.021
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.021
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.021
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.021
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.021
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.021
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.021
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.021
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.021
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.021
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.021
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.021
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.021
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.020
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.020
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.020
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.020
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.020
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.020
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.020
|
|
|
|
fear response
|
GO:0042596 |
33 |
0.020
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.020
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.020
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.020
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.020
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.020
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.020
|
|
|
|
establishment or maintenance of apical basal cell polarity
|
GO:0035088 |
21 |
0.020
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.020
|
|
|
|
positive regulation of oligodendrocyte differentiation
|
GO:0048714 |
9 |
0.020
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.020
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.020
|
|
|
|
regulation of calcium mediated signaling
|
GO:0050848 |
19 |
0.020
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.019
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.019
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.019
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.019
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.019
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.019
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.019
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.019
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.019
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.019
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.019
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.019
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.019
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.019
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.019
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.019
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.019
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.019
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.019
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.019
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.019
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.019
|
|
|
|
regulation of dna binding
|
GO:0051101 |
39 |
0.019
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.019
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.018
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.018
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.018
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.018
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.018
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.018
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.018
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.018
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.018
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.018
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.018
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.018
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.018
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.018
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.018
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.018
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.018
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.018
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.018
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.018
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.018
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.018
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.017
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.017
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.017
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.017
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.017
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.017
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.017
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.017
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.017
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.017
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.017
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.017
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.017
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.017
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.017
|
|
|
|
negative regulation of tumor necrosis factor production
|
GO:0032720 |
17 |
0.017
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.017
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.017
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.017
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.017
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.017
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.017
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.017
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.017
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.017
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.017
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.017
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.017
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.017
|
|
|
|
eye pigmentation
|
GO:0048069 |
3 |
0.017
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.017
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.017
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.016
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.016
|
|
|
|
retina layer formation
|
GO:0010842 |
16 |
0.016
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.016
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.016
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.016
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.016
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.016
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.016
|
|
|
|
regulation of cytokine production involved in immune response
|
GO:0002718 |
26 |
0.016
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.016
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.016
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.016
|
|
|
|
dorsal ventral neural tube patterning
|
GO:0021904 |
28 |
0.016
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.016
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.016
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.016
|
|
|
|
positive regulation of epithelial to mesenchymal transition
|
GO:0010718 |
13 |
0.016
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.016
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.016
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.016
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.016
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.016
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.016
|
|
|
|
proton transport
|
GO:0015992 |
35 |
0.016
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.016
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.016
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.016
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.016
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.016
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.016
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.016
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.015
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.015
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.015
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.015
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.015
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.015
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.015
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.015
|
|
|
|
mitochondrial transport
|
GO:0006839 |
36 |
0.015
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.015
|
|
|
|
spinal cord patterning
|
GO:0021511 |
25 |
0.015
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.015
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.015
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.015
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.015
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.015
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.015
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.015
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.015
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.015
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.015
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.015
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.015
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.015
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.015
|
|
